[1]
O. A. Panibratiuk and Yakovleva O. А., “ASSESSMENT OF BLEEDING RISK FACTORS DURING WARFARIN THERAPY IN ISCHEMIC HEART DISEASE COMPLICATED BY ATRIAL FIBRILLATION”, MCCh, no. 2, pp. 24–32, Oct. 2022.